Navegar por autor "Castellanos Diez, Javier"

Mostrando ítems 1-5 de 5

Non-randomized, open label phase II trial evaluating the safety and efficacy of taxotere (T) followed by myocet (M) + cyclophosphamide (C) as first-line treatment for HER2-negative breast cancer (BC)

2011- Calvo Martínez, Lourdes; García Mata, Jesús; López López, Rafael; Castellanos Diez, Javier
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer

2015- Gallardo Martín , Maria Elena; Fernández Montes, Ana; Varela Ferreiro, Silvia; Campos Balea, Begoña; Álvarez Gómez, Elena; [et al.]
Randomized phase II study of abiraterone acetate maintenance in combination with docetaxel after disease progression to abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC): ABIDO SOGUG trial

2014- Castellanos Diez, Javier
Self-examination and risk groups in screening breast cancer

2013- Senin Estor, Clara; Castellanos Diez, Javier; Fernández Pérez, Isaura; García Cid, Noelia; Alonso Herrero, Ana [et al.]
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)

2014- Castellanos Diez, Javier